The main news on vaccines this week centers on several significant policy changes, clinical trial results, and developments in the U.S. and global vaccine policy landscape that touch on these controversies. Key Vaccine...
Moderna, once celebrated for its rapid development of a lifesaving COVID-19 vaccine during the initial Trump administration, now finds itself navigating a dramatically changed landscape as the U.S. government tightens...
Novavax announced a significant regulatory milestone: the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™, its recombinant protein-based, non-mRNA COVID-19...
A new study by researchers at the University of Oxford has shed light on how COVID-19 vaccines reduce the severity of illness, even when vaccinated people do get infected. The findings help explain why vaccinated...
Neither money nor other nudges are enough to persuade vaccine-hesitant people to get the COVID-19 vaccine, a new USC study shows. The findings, published recently in the journal Vaccine, suggest the standard public...
A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the COVID-19 vaccination. The...
The fourth wave of the COVID-19 pandemic is putting pressure on hospital networks, upsetting many and making vaccine refusals seem foolish. To better understand what leads someone refuse or delay vaccination, it is...
In a significant move to combat the Covid-19 pandemic, the U.S. government agreed to support a controversial proposal to temporarily waive intellectual property rights for vaccines in a bid to increase global supplies...
Bharat Biotech has reported that interim analysis results from the Phase III trial of its Covid-19 vaccine COVAXIN showed a 100% efficacy against severe SARS-CoV-2 infection and has an impact on the drop in...
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce. Experts estimate that 80 percent of people in low-resource countries will not receive a...